Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01829620 · ClinicalTrials.gov registry record · NA

Military Continuity Project

A NA study, sponsored by University of Washington.

Completed
Registry status
NA
Development phase
658
Enrollment target

NCT01829620 is a NA study that has completed, run by University of Washington. The registered enrollment target is 658 participants.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01829620, a NA study, has completed, sponsored by University of Washington.

COMPLETED
Registry status
NA
Development phase
658 participants
Enrollment target

Study Summary

The investigators propose to utilize text messaging to create and investigate the efficacy of a Continuing Contacts via Text (CCVT) intervention that extends the continuity of care for Service Members with a recent suicide attempt and/or reported suicidal ideation by sending them non-demanding caring text messages at regular intervals over a 12-month period. Participants will be randomly assigned to receive Continuing Contacts via Text (CCVT) in addition to Treatment as Usual (TAU) or TAU alone. Aim 1: To determine if the addition of 12 months of CCVT to TAU (CCVT+TAU) results in lower rates of suicidal ideation and behavior relative to TAU alone. * Hypothesis 1a: Participants assigned to CCVT+TAU compared to TAU alone will experience reduced suicidal ideation at 12-month follow-up. * Hypothesis 1b: Over the 12 months following study enrollment, a smaller proportion of participants assigned to CCVT+TAU vs. TAU alone will have suicide risk incidents (i.e., those requiring medical evacuation or hospital admission). * Hypothesis 1c: Over the 12 months following study enrollment, CCVT+TAU vs. TAU alone will have fewer total number of suicide risk incidents requiring medical evacuation or hospital admission. Aim 2: To test two proposed mechanisms of action of CCVT outcome: 1) reduced "thwarted belongingness" and 2) increased engagement in behavioral health services. * Hypothesis 2a: The effect of CCVT+TAU compared to TAU alone will be mediated by reductions in "thwarted belongingness" from pre to post-study. * Hypothesis 2b: The effect of CCVT+TAU compared to TAU alone will be mediated by increased use of outpatient behavioral health services in the CCVT+TAU condition.

Interventions

  • BEHAVIORAL TAU
  • BEHAVIORAL CCVT+TAU

Trial Details

FieldValue
Enrollment Target 658 participants
Start Date 2013-04
Est. Completion 2018-04
Phase NA

Sponsor

University of Washington

1,048 total trials

What the Registry Record Tells You About NCT01829620

The ClinicalTrials.gov registry entry for NCT01829620 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 658 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Washington, which has 1,048 total studies on file at ClinicalTrials.gov.

The record links to 0 conditions, and to 2 interventions - of which TAU is the first listed.

NCT01829620 reports 0 study locations.

Frequently Asked Questions

What is clinical trial NCT01829620 about?

NCT01829620 is a clinical study titled "Military Continuity Project". The investigators propose to utilize text messaging to create and investigate the efficacy of a Continuing Contacts via Text (CCVT) intervention that extends the continuity of care for Service Members with a recent suicide attempt and/or reported suicidal ideation by sending them non-demanding carin...

What is the current status of trial NCT01829620?

This trial is currently completed. It is a NA study. The enrollment target is 658 participants. The study started on 2013-04. Estimated completion is 2018-04.

What interventions are being tested in trial NCT01829620?

The interventions under investigation include: TAU (BEHAVIORAL), CCVT+TAU (BEHAVIORAL).

Who is sponsoring clinical trial NCT01829620?

This trial is sponsored by University of Washington, which has 1,048 total clinical trials registered on ClinicalTrials.gov.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.